We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Encephalitis

News List

Valneva initiates Phase 1/2 clinical study of inactivated, adjuvanted COVID-19 vaccine candidate worldpharmanews
December 17, 2020
Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
Valneva Wins DoD Contract for IXIARO contractpharma
September 14, 2020
Will supply Japanese encephalitis vaccine IXIARO under a new contract lasting up to three years.
Recommendations Developed for Japanese Encephalitis Vaccine drugs
July 22, 2019
In the issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report...